In: The MD Anderson Manual of Medical Oncology, 2nd Edition. Blood 123(19):2905-6, 2014. J Clin Oncol ASCO Annual Meeting(8523), 2013. . Clinico-Pathological Characteristics, Treatments and Outcomes of Patients with Dendritic Cell Sarcoma (DS). Your gift will help support our mission to end cancer and make a difference in the lives of our patients. Blood 126(23):5126, 2015. . The Indolent Lymphomas. Odell Anderson Rivers age 90 of Birmingham passed away Jan 6, 2021 one week to the day of his wife Barbara Lee Rivers of 67 years. Expert Rev Pharmacoecon Outcomes Res 5(2):153-62, 2005. Outcomes of De Novo CD5+ Diffuse Large B-Cell Lymphoma (DLBCL) in The Rituximab (R) Era. Update on a phase I study of the selective PI3Kδ inhibitor idelalisib (GS-1101) in combination with rituximab and/or bendamustine in patients with relapsed or refractory CLL. BMC Health Serv Res 9:9, 2009. e-Pub 2009. The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma. Leuk Lymphoma 55(5):1013-7, 2014. e-Pub 2013. Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma. He attended and graduated from Stanford University School Of Medicine in 1997, having over 23 years of diverse experience, especially in Medical Oncology. https://www.healthgrades.com/physician/dr-robin-anderson-2wrff Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular, and transformed lymphoma: a phase II clinical trial. Obinutuzumab plus CHOP is effective and has a tolerable safety profile in previously untreated, advanced diffuse large B-cell lymphoma: the phase II GATHER study. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. Follicular lymphoma in the United States: first report of the national LymphoCare study. Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?. Learn about our graduate medical education residency and fellowship opportunities. PMID: 25052052. . Department of Lymphoma - Myeloma, Division of Cancer Medicine, Department Chair, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, © 2021 The University of Texas MD Anderson Cancer Center. J Clin Oncol 33(21):2399-404, 2015. e-Pub 2015. PMID: 23143597. . Our patients have access to clinical trials offering promising new Since joining the faculty at MD Anderson Cancer Center, the goal of my clinical research has been to further develop novel therapeutic regimens utilizing immunomodulatory agents to benefit patients with low grade non-Hodgkins lymphoma. He was born March 8, 1925, to Columbus Irdell Galyen and Edna Luchester (Weatherford) Galyen. Clin Lymphoma Myeloma Leuk 15(5):270-7, 2015. e-Pub 2014. PMID: 27502933. . Dr. Christopher R. Flowers is an oncologist in Atlanta, Georgia and is affiliated with multiple hospitals in the area. PMID: 30714446. . Diffuse large B-cell lymphoma (DLBCL) with bone marrow (BM) involvement, clinica presentation, central nervous system (CNS) relapses, and outcomes of 121 patients treated at M.D. PMID: 30480777. . Blood 124:498, 2014. . PMID: 28817403. . Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donors. PMID: 12886175. . PMID: 26443656. . Biol Blood Marrow Transplant 22(7):1197-1205, 2016. e-Pub 2016. A Markov model assessing the effectiveness and cost-effectiveness of FOLFOX compared with FOLFIRI for the initial treatment of metastatic colorectal cancer. Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial. Choose from 12 allied health programs at School of Health Professions. Bortezomib, bendamustine, and rituximab in patients with relapsed or refractory follicular lymphoma: The phase II VERTICAL study. R-HCVAD alternating with R-methotrexate cytrabine in younger patients (pts) with IH and high-risk age adjusted-IPI DLBCL. Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma. Leuk Lymphoma 60(13):1-10, 2019. e-Pub 2019. J Immunol 190(12):6681-93, 2013. e-Pub 2013. ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma. A Greenbrier County native, Dr. Anderson began her career as a registered nurse. PMID: 29654427. . Blood 124:801, 2014. . PMID: 22677155. . Dr. BMJ Open 5(10):e008350, 2015. e-Pub 2015. PMID: 26195701. . PMID: 27085537. . Management Strategies and Outcomes for Very Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL). PMID: 24607557. . Ann Oncol. Population-specific prognostic models are needed to stratify outcomes for African-Americans with diffuse large B-cell lymphoma. Ethnic disparity in primary cutaneous CD30+ T-cell lymphoproliferative disorders: an analysis of 1496 cases from the US National Cancer database. Practical approach for using Medicare data to estimate costs for cost-effectiveness analysis. Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy. J Clin Oncol 29(20):2787-94, 2011. e-Pub 2011. Prosurvival and Chemoprotective Effects of Tumor-Associated Macrophages Reversed By Anti-CSF-1R Monoclonal Antibody in B-Cell Lymphomas. Chase Anderson, MD. PMID: 26124482. . He graduated from Meharry Medical College medical school in 1982. Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement. J Am Coll Surg 196(3):385-93, 2003. He is affiliated with many hospitals including Emory Johns Creek Hospital, Emory University Hospital, Emory University Hospital Midtown, Saint Joseph's Hospital Of Atlanta Inc. Dr. Christopher R Flowers also cooperates with other doctors and physicians in medical gro… Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States. Cancer 121(11):1800-8, 2015. e-Pub 2015. Blood (ASH Annual Meeting Abstracts) 120(21), 2012. . A biologic combination of lenalidomide and rituximab for front-Line therapy of indolent b-cell non-Hodgkin's lymphoma. Haematologica 100(11):e454-7, 2015. e-Pub 2015. In: Surgery of the Breast: Principles and Art. Cancer Epidemiol Biomarkers Prev 26(3):303-311, 2017. e-Pub 2016. Leuk Lymphoma 59(7):1700-1709, 2018. e-Pub 2017. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. PMID: 24043736. . Blood (ASH Annual Meeting Abstracts) 116(21), 2010. . Clin Lymphoma Myeloma Leuk 14(6):460-467.e2, 2014. e-Pub 2014. PMID: 26759182. . Clinical investigators as critical determinants in pharmaceutical innovation. Blood 124:4448, 2014. . Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters. Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial. Leuk Lymphoma 57(1):1-5, 2016. e-Pub 2015. Biol Blood Marrow Transplant 23(7):1117-1121, 2017. e-Pub 2017. PMID: 23896932. . J Clin Oncol ASCO Annual Meeting(8500), 2013. . He was preceded in death by his parents; and his wife of 66 years, Emogene Rose Galyen, who passed away in 2016. Integrating emerging treatment options in mantle cell lymphoma. Eur J Cancer 54:11-17, 2016. e-Pub 2015. A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma. Br J Haematol 184(4):660-663, 2019. e-Pub 2018. Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes. Medical School: ... Michael Flowers, M.D. Does the addition of involved field radiotherapy to high-dose chemotherapy and stem cell transplantation improve outcomes for patients with relapsed/refractory Hodgkin lymphoma?. Leuk Lymphoma 60(8):1965-1971, 2019. e-Pub 2019. Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study. Biol Blood Marrow Transplant 19:460-467, 2013. . PMID: 23041589. . Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study. If you are ready to make an appointment, select a button on the right. Clin Cancer Res 16(20):5079-86, 2010. e-Pub 2010. Complete remission following lenalidomide and rituximab in a patient with heavily pretreated nodular lymphocyte predominant Hodgkin lymphoma. Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. PMID: 26250576. . J Clin Oncol ASCO Annual Meeting(8501), 2013. . Racial and Socioeconomic Disparities in Mantle Cell Lymphoma. Phase II safety and efficacy study of pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma. Ann Oncol 29(8):1822-1827, 2018. Haematologica. In: Advances in Malignant Hematology. Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis. Lenalidomide and rituximab for untreated indolent lymphoma: Final results of a phase II study. PMID: 26402559. . Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Antibiotic Therapy of H. Pylori Negative Gastric MALT Lymphoma. Our industry-leading, speech-to-text algorithms will convert audio & video files to text in minutes. Complete response rates with lenalidomide plus rituximab for untreated indolent B-cell non-Hodgkin's lymphoma. Christopher Maisel, MD, Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas. A cost-effectiveness analysis of intraoperative cholangiography in the prevention of bile duct injury during laparoscopic cholecystectomy. PMID: 24668580. . Blood (ASH Annual Meeting Abstracts) 118(21), 2011. . Leuk Lymphoma 56(2):383-9, 2015. e-Pub 2014. Flowers is usually the first point of contact for patients searching for general or primary medical care & can recommend patients to a specialist when necessary. PMID: 22370160. . PMID: 27067436. . PMID: 27153197. . He accepts multiple insurance plans. A systematic literature review and meta-analysis of radioimmunotherapy consolidation for patients with untreated follicular lymphoma. Blood 124(15):2354-61, 2014. e-Pub 2014. Medical School: Texas Tech University Health Science Center Undergraduate School: ... Dylan Constantino, MD. Log in to our secure, personalized website to manage your care (formerly myMDAnderson). PMID: 22624594. . Survival Outcomes of Primary Intraocular Lymphoma: A Single-institution Experience. PMID: 28736638. . Phase II study with R-FND followed by 90-Y Ibritumomab tiuxetan radioimmuntherapy and rituximab maintenance for untreated high-risk follicular lymphoma. information page may be the best place to start. Blood 128(3):331-336, 2016. . Cheson, DeVos S, Wilson W, Gerecitano J, Goy A, Kenkre V, Barr P, Blum K, Shustov A, Advani R, Fowler N, Vose J, Lih C, Williams M, Schmitz R, Yang Y, Pittaluga S, Wright, G, Kunkel L, McGreivy J, Beaurpe D, Balasubramanian S, Cheng M, Moussa D, Chang L, Buggy J, Staudt L, Westin J, Chu F, Fayad L, Kwak L, Fowler N, Romaguera J, Hagemeister F, Allen R, Feng L, Baladandayuthapani V, Yehudar R, Davis E, Neelapu S, Coutre S, Leonard J, Furman R, Flinn I, de Vos S, Rai K, Schreeder M, Wagner-Johnston, Sharman J, Boyd T, Fowler N, Kim Y, Holes L, Johnson D, Dansey R, Jahn T, Barrientos J. Nastoupil L, Cheah CY, Medeiros LJ, Fowler N. Indolent Lymphomas. Clin Lymphoma Myeloma Leuk 11(5):379-84, 2011. e-Pub 2011. Oral lenalidomide plus 4 doses of rituximab induced prolonged remissions in a cohort of patients with DLBCL and grade 3 follicular lymphoma: a completed phase II clinical trial. Blood (ASH Annual Meeting Abstracts) 114(22):48, 2009. . J Clin Oncol 35(5):552-560, 2017. . PMID: 22771484. . Cancer Epidemiol 41:139-51, 2016. e-Pub 2016. Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma. Blood 126(23):1502, 2015. . J Clin Oncol 31(6):794-810, 2013. e-Pub 2013. Br J Haematol. Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma. Cenveo: New York, USA, 133-151, 2016. Hours. Detection of circulating tumour DNA in patients with aggressive B-cell Non-Hodgkin lymphoma. Franklin Flowers, MD Chief, Division of Dermatology, Professor, Department of Medicine and Otolaryngology, Affiliate Associate Professor of Pediatrics and Pathology, University of Florida College of Medicine. PMID: 23795711. . PMID: 30179565. . Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma. Surveillance computed tomography scans for patients with lymphoma: is the risk worth the benefits?. PMID: 28482717. . Specialized Programs of Research Excellence (SPORE) Grants, Prevention & Personalized Risk Assessment, Office of Clinical Research Administration, Comparative Effectiveness Training (CERTaIN), Post Graduate Fellowship in Oncology Nursing, Professional Student Nurse Extern Programs, Goldstein JS, Switchenko JM, Behera M, Flowers CR, Koff JL, Teras LR, Diver WR, Deubler EL, Krewski D, Flowers CR, Switchenko JM, Gapstur SM, Ritter AJ, Goldstein JS, Ayers AA, Flowers CR, Çaglayan Ç, Goldstein JS, Ayer T, Rai A, Flowers CR, Shah NN, Xi Y, Liu Y, Koff JL, Flowers CR, Behera M, Cohen JB, Çaglayan Ç, Terawaki H, Ayer T, Goldstein JS, Rai A, Chen Q, Flowers C, Chang A, Payne JB, Allen PB, Koff JL, Ahmed R, Flowers CR, Bednarczyk RA, Badar T, Hamadani M, Bachanova V, Maddocks KJ, Umyarova E, Chavez JC, Epperla N, Chhabra S, Xavier AC, Karmali R, Salhab M, Reddy N, Glenn MJ, Hernandez-Ilizaliturri FJ, Flowers CR, Evens AM, Zhou Z, Lansigan F, Barta SK, Cohen JB, Fenske TS, Costa LJ, Sharman JP, Forero-Torres A, Costa LJ, Flinn IW, Inhorn L, Kelly K, Bessudo A, Fayad LE, Kaminski MS, Evens AM, Flowers CR, Sahin D, Mundt KE, Sandmann T, Fingerle-Rowson G, Vignal C, Mobasher M, Zelenetz AD, Nastoupil LJ, Lunning MA, Vose JM, Schreeder MT, Siddiqi T, Flowers CR, Cohen JB, Burger JA, Wierda WG, O'Brien S, Sportelli P, Miskin HP, Purdom MA, Weiss MS, Fowler NH, Link BK, Day BM, Zhou X, Zelenetz AD, Dawson KL, Cerhan JR, Flowers CR, Friedberg JW, Joseph NS, Kaufman JL, Boise LH, Valla K, Almaula DK, Obidike CO, Langston AA, Waller EK, Khoury HJ, Flowers CR, Graiser M, Heffner LT, Lonial S, Nooka AK, Calzada O, Switchenko JM, Maly JJ, Blum KA, Grover N, Mathews S, Park SI, Gordon M, Danilov A, Epperla N, Fenske TS, Hamadani M, Flowers CR, Cohen JB, Pophali PA, Ip A, Larson MC, Rosenthal AC, Maurer MJ, Flowers CR, Link BK, Farooq U, Feldman AL, Allmer C, Slager SL, Witzig TE, Habermann TM, Cohen JB, Cerhan JR, Thompson CA, Blum KA, Keller FG, Castellino S, Phan A, Flowers CR, Flowers CR, Nabhan C, Kay NE, Mato A, Lamanna N, Farber CM, Davids MS, Kiselev P, Swern AS, Sullivan K, Flick ED, Sharman JP, Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, Langston AA, Nastoupil LJ, Rajotte M, Rolston KV, Strasfeld L, Flowers CR, de Vos S, Swinnen LJ, Wang D, Reid E, Fowler N, Cordero J, Dunbar M, Enschede SH, Nolan C, Petrich AM, Ross JA, Salem AH, Verdugo M, Agarwal S, Zhou L, Kozloff M, Nastoupil LJ, Flowers CR, Goldstein JS, Nastoupil LJ, Han X, Jemal A, Ward E, Flowers CR, Shi Q, Schmitz N, Ou FS, Dixon JG, Cunningham D, Pfreundschuh M, Seymour JF, Jaeger U, Habermann TM, Haioun C, Tilly H, Ghesquieres H, Merli F, Ziepert M, Herbrecht R, Flament J, Fu T, Coiffier B, Flowers CR, Yazbeck V, Shafer D, Perkins EB, Coppola D, Sokol L, Richards KL, Shea T, Ruan J, Parekh S, Strair R, Flowers C, Morgan D, Kmieciak M, Bose P, Kimball A, Badros AZ, Baz R, Lin HY, Zhao X, Reich RR, Tombes MB, Shrader E, Sankala H, Roberts JD, Sullivan D, Grant S, Holkova B, Kleinstern G, Maurer MJ, Liebow M, Habermann TM, Koff JL, Allmer C, Witzig TE, Nowakowski GS, Micallef IN, Johnston PB, Inwards DJ, Thompson CA, Feldman AL, Link BK, Flowers C, Slager SL, Cerhan JR, Maurer MJ, Habermann TM, Shi Q, Schmitz N, Cunningham D, Pfreundschuh M, Seymour JF, Jaeger U, Haioun C, Tilly H, Ghesquieres H, Merli F, Ziepert M, Herbrecht R, Flament J, Fu T, Flowers CR, Coiffier B, Chen Q, Staton AD, Ayer T, Goldstein DA, Koff JL, Flowers CR, Wang SS, Carrington M, Berndt SI, Slager SL, Bracci PM, Voutsinas J, Cerhan JR, Smedby KE, Hjalgrim H, Vijai J, Morton LM, Vermeulen R, Paltiel O, Vajdic CM, Linet MS, Nieters A, de Sanjose S, Cozen W, Brown EE, Turner J, Spinelli JJ, Zheng T, Birmann BM, Flowers CR, Becker N, Holly EA, Kane E, Weisenburger D, Maynadie M, Cocco P, Albanes D, Weinstein SJ, Teras LR, Diver WR, Lax SJ, Travis RC, Kaaks R, Riboli E, Benavente Y, Brennan P, McKay J, Delfau-Larue MH, Link BK, Magnani C, Ennas MG, Latte G, Feldman AL, Doo NW, Giles GG, Southey MC, Milne RL, Offit K, Musinsky J, Arslan AA, Purdue MP, Adami HO, Melbye M, Glimelius B, Conde L, Camp NJ, Glenn M, Curtin K, Clavel J, Monnereau A, Cox DG, Ghesquières H, Salles G, Bofetta P, Foretova L, Staines A, Davis S, Severson RK, Lan Q, Brooks-Wilson A, Smith MT, Roman E, Kricker A, Zhang Y, Kraft P, Chanock SJ, Rothman N, Hartge P, Skibola CF, Wolf AMD, Fontham ETH, Church TR, Flowers CR, Guerra CE, LaMonte SJ, Etzioni R, McKenna MT, Oeffinger KC, Shih YT, Walter LC, Andrews KS, Brawley OW, Brooks D, Fedewa SA, Manassaram-Baptiste D, Siegel RL, Wender RC, Smith RA, Casulo C, Friedberg JW, Ahn KW, Flowers C, DiGilio A, Smith SM, Ahmed S, Inwards D, Aljurf M, Chen AI, Choe H, Cohen J, Copelan E, Farooq U, Fenske TS, Freytes C, Gaballa S, Ganguly S, Jethava Y, Kamble RT, Kenkre VP, Lazarus H, Lazaryan A, Olsson RF, Rezvani AR, Rizzieri D, Seo S, Shah GL, Shah N, Solh M, Sureda A, William B, Cumpston A, Zelenetz AD, Link BK, Hamadani M, Greenwell IB, Staton AD, Lee MJ, Switchenko JM, Saxe DF, Maly JJ, Blum KA, Grover NS, Mathews SP, Gordon MJ, Danilov AV, Epperla N, Fenske TS, Hamadani M, Park SI, Flowers CR, Cohen JB, Keegan THM, Li Q, Steele A, Alvarez EM, Brunson A, Flowers CR, Glaser SL, Wun T, Koff JL, Li JX, Zhang X, Switchenko JM, Flowers CR, Waller EK, Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, Langston AA, Nastoupil LJ, Rajotte M, Rolston K, Strasfeld L, Flowers CR, Guidot DM, Switchenko JM, Nastoupil LJ, Koff JL, Blum KA, Maly J, Flowers CR, Cohen JB, Mato A, Nabhan C, Kay NE, Lamanna N, Kipps TJ, Grinblatt DL, Flowers CR, Farber CM, Davids MS, Kiselev P, Swern AS, Bhushan S, Sullivan K, Flick ED, Sharman JP, Petersen CT, Hassan M, Morris AB, Jeffery J, Lee K, Jagirdar N, Staton AD, Raikar SS, Spencer HT, Sulchek T, Flowers CR, Waller EK, Ahn IE, Farber CM, Davids MS, Grinblatt DL, Kay NE, Lamanna N, Mato A, Nabhan C, Kiselev P, Swern AS, Flick ED, Sullivan K, Sharman JP, Flowers CR, Epperla N, Maddocks KJ, Salhab M, Chavez JC, Reddy N, Karmali R, Umyarova E, Bachanova V, Costa C, Glenn M, Calzada O, Xavier AC, Zhou Z, Hossain NM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Barta SK, Chhabra S, Lansigan F, Mehta A, Jaglal MV, Evens AM, Flowers CR, Cohen JB, Fenske TS, Hamadani M, Costa LJ, Leonard JP, Kolibaba KS, Reeves JA, Tulpule A, Flinn IW, Kolevska T, Robles R, Flowers CR, Collins R, DiBella NJ, Papish SW, Venugopal P, Horodner A, Tabatabai A, Hajdenberg J, Park J, Neuwirth R, Mulligan G, Suryanarayan K, Esseltine DL, de Vos S, Lin RJ, Behera M, Diefenbach CS, Flowers CR, Reddy A, Zhang J, Davis NS, Moffitt AB, Love CL, Waldrop A, Leppa S, Pasanen A, Meriranta L, Karjalainen-Lindsberg ML, Nørgaard P, Pedersen M, Gang AO, Høgdall E, Heavican TB, Lone W, Iqbal J, Qin Q, Li G, Kim SY, Healy J, Richards KL, Fedoriw Y, Bernal-Mizrachi L, Koff JL, Staton AD, Flowers CR, Paltiel O, Goldschmidt N, Calaminici M, Clear A, Gribben J, Nguyen E, Czader MB, Ondrejka SL, Collie A, Hsi ED, Tse E, Au-Yeung RKH, Kwong YL, Srivastava G, Choi WWL, Evens AM, Pilichowska M, Sengar M, Reddy N, Li S, Chadburn A, Gordon LI, Jaffe ES, Levy S, Rempel R, Tzeng T, Happ LE, Dave T, Rajagopalan D, Datta J, Dunson DB, Dave SS, Cohen JB, Maddocks KJ, Huang Y, Christian BA, Jaglowski SM, Flowers CR, Blum KA, Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED, Rai A, Nastoupil LJ, Williams JN, Lipscomb J, Ward KC, Howard DH, Lee D, Flowers CR, Guo X, Koff JL, Moffitt AB, Cinar M, Ramachandiran S, Chen Z, Switchenko JM, Mosunjac M, Neill SG, Mann KP, Bagirov M, Du Y, Natkunam Y, Khoury HJ, Rossi MR, Harris W, Flowers CR, Lossos IS, Boise LH, Dave SS, Kowalski J, Bernal-Mizrachi L, Hamilton BK, Rybicki L, Abounader D, Adekola K, Advani A, Aldoss I, Bachanova V, Bashey A, Brown S, DeLima M, Devine S, Flowers CR, Ganguly S, Jagasia M, Kennedy VE, Kim DDH, McGuirk J, Pullarkat V, Romee R, Sandhu K, Smith M, Ueda M, Viswabandya A, Vu K, Wall S, Zeichner SB, Perales MA, Majhail NS, Tao L, Clarke CA, Rosenberg AS, Advani RH, Jonas BA, Flowers CR, Keegan THM, Goldstein DA, Chen Q, Ayer T, Chan KKW, Virik K, Hammerman A, Brenner B, Flowers CR, Hall PS, Gopal AK, Kahl BS, Flowers CR, Martin P, Ansell SM, Abella-Dominicis E, Koh B, Ye W, Barr PM, Salles GA, Friedberg JW, Shah NN, McClellan W, Flowers CR, Lonial S, Khoury H, Waller EK, Langston A, Nooka AK, Zeichner SB, Goldstein DA, Kohn C, Flowers CR, Kohn CG, Zeichner SB, Chen Q, Montero AJ, Goldstein DA, Flowers CR, McKinney M, Moffitt AB, Gaulard P, Travert M, De Leval L, Nicolae A, Raffeld M, Jaffe ES, Pittaluga S, Xi L, Heavican T, Iqbal J, Belhadj K, Delfau-Larue MH, Fataccioli V, Czader MB, Lossos IS, Chapman-Fredricks JR, Richards KL, Fedoriw Y, Ondrejka SL, Hsi ED, Low L, Weisenburger D, Chan WC, Mehta-Shah N, Horwitz S, Bernal-Mizrachi L, Flowers CR, Beaven AW, Parihar M, Baseggio L, Parrens M, Moreau A, Sujobert P, Pilichowska M, Evens AM, Chadburn A, Au-Yeung RK, Srivastava G, Choi WW, Goodlad JR, Aurer I, Basic-Kinda S, Gascoyne RD, Davis NS, Li G, Zhang J, Rajagopalan D, Reddy A, Love C, Levy S, Zhuang Y, Datta J, Dunson DB, Davé SS, Noy A, de Vos S, Thieblemont C, Martin P, Flowers CR, Morschhauser F, Collins GP, Ma S, Coleman M, Peles S, Smith S, Barrientos JC, Smith A, Munneke B, Dimery I, Beaupre DM, Chen R, Salles G, Schuster SJ, de Vos S, Wagner-Johnston ND, Viardot A, Blum KA, Flowers CR, Jurczak WJ, Flinn IW, Kahl BS, Martin P, Kim Y, Shreay S, Will M, Sorensen B, Breuleux M, Zinzani PL, Gopal AK, Wong-Sefidan I, Byrtek M, Zhou X, Friedberg JW, Flowers CR, Zelenetz AD, Dawson KL, Reid E, Han X, Jemal A, Hulland E, Simard EP, Nastoupil L, Ward E, Flowers CR, Nabhan C, Mato A, Flowers CR, Grinblatt DL, Lamanna N, Weiss MA, Davids MS, Swern AS, Bhushan S, Sullivan K, Flick ED, Kiselev P, Sharman JP, Shi Q, Flowers CR, Hiddemann W, Marcus R, Herold M, Hagenbeek A, Kimby E, Hochster H, Vitolo U, Peterson BA, Gyan E, Ghielmini M, Nielsen T, De Bedout S, Fu T, Valente N, Fowler NH, Hoster E, Ladetto M, Morschhauser F, Zucca E, Salles G, Sargent DJ, Costa LJ, Maddocks K, Epperla N, Reddy NM, Karmali R, Umyarova E, Bachanova V, Costa C, Glenn MJ, Chavez JC, Calzada O, Lansigan F, Nasheed H, Barta SK, Zhou Z, Jaglal M, Chhabra S, Hernandez-Ilizaliturri F, Xavier AC, Mehta A, Peker D, Forero-Torres A, Al-Mansour Z, Evens AM, Cohen JB, Flowers CR, Fenske TS, Hamadani M, Chen Q, Jain N, Ayer T, Wierda WG, Flowers CR, O'Brien SM, Keating MJ, Kantarjian HM, Chhatwal J, Danish HH, Liu S, Jhaveri J, Flowers CR, Lechowicz MJ, Esiashvili N, Khan MK, Dhakal S, Advani R, Ballas LK, Dabaja BS, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Younes A, Constine LS, Expert Panel on Radiation Oncology–Lymphoma, Mato A, Nabhan C, Kay NE, Weiss MA, Lamanna N, Kipps TJ, Grinblatt DL, Flinn IW, Kozloff MF, Flowers CR, Farber CM, Kiselev P, Swern AS, Sullivan K, Flick ED, Sharman JP, Winkfield KM, Advani RH, Ballas LK, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mansur DB, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Younes A, Constine LS, Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR, Bulka C, Nastoupil LJ, Koff JL, Bernal-Mizrachi L, Ward KC, Williams JN, Bayakly AR, Switchenko JM, Waller LA, Flowers CR, Cassidy RJ, Jegadeesh N, Switchenko J, Danish H, Esiashvili N, Flowers CR, Khan MK, Cohen JB, Han X, Jemal A, Ward EM, Flowers CR, DeFilipp Z, Langston AA, Chen Z, Zhang C, Arellano ML, El Rassi F, Flowers CR, Kota VK, Al-Kadhimi Z, Veldman R, Jillella AP, Lonial S, Waller EK, Khoury HJ, Nabhan C, Zhou X, Day BM, Dawson K, Zelenetz AD, Friedberg JW, Cerhan JR, Link BK, Flowers CR, Roberts KB, Younes A, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Constine LS, Expert Panel on Radiation OncologyLymphoma, Flowers CR, Costa LJ, Pasquini MC, Le-Rademacher J, Lill M, Shore TB, Vaughan W, Craig M, Freytes CO, Shea TC, Horwitz ME, Fay JW, Mineishi S, Rondelli D, Mason J, Braunschweig I, Ai W, Yeh RF, Rodriguez TE, Flinn I, Comeau T, Yeager AM, Pulsipher MA, Bence-Bruckler I, Laneuville P, Bierman P, Chen AI, Kato K, Wang Y, Xu C, Smith AJ, Waller EK, Moss E, Goldstein DA, Bradley KT, Flowers CR, Murphy DA, Danish HH, Heumann TR, Bradley KT, Switchenko J, Esiashvili N, Lechowicz MJ, Flowers CR, Khan MK, Goldstein DA, Krishna K, Flowers CR, El-Rayes BF, Bekaii-Saab T, Noonan AM, Deng J, Pennati A, Cohen JB, Wu Y, Ng S, Wu JH, Flowers CR, Galipeau J, Machiela MJ, Lan Q, Slager SL, Vermeulen RC, Teras LR, Camp NJ, Cerhan JR, Spinelli JJ, Wang SS, Nieters A, Vijai J, Yeager M, Wang Z, Ghesquières H, McKay J, Conde L, de Bakker PI, Cox DG, Burdett L, Monnereau A, Flowers CR, De Roos AJ, Brooks-Wilson AR, Giles GG, Melbye M, Gu J, Jackson RD, Kane E, Purdue MP, Vajdic CM, Albanes D, Kelly RS, Zucca M, Bertrand KA, Zeleniuch-Jacquotte A, Lawrence C, Hutchinson A, Zhi D, Habermann TM, Link BK, Novak AJ, Dogan A, Asmann YW, Liebow M, Thompson CA, Ansell SM, Witzig TE, Tilly H, Haioun C, Molina TJ, Hjalgrim H, Glimelius B, Adami HO, Roos G, Bracci PM, Riby J, Smith MT, Holly EA, Cozen W, Hartge P, Morton LM, Severson RK, Tinker LF, North KE, Becker N, Benavente Y, Boffetta P, Brennan P, Foretova L, Maynadie M, Staines A, Lightfoot T, Crouch S, Smith A, Roman E, Diver WR, Offit K, Zelenetz A, Klein RJ, Villano DJ, Zheng T, Zhang Y, Holford TR, Turner J, Southey MC, Clavel J, Virtamo J, Weinstein S, Riboli E, Vineis P, Kaaks R, Boeing H, Tjønneland A, Angelucci E, Di Lollo S, Rais M, De Vivo I, Giovannucci E, Kraft P, Huang J, Ma B, Ye Y, Chiu BC, Liang L, Park JH, Chung CC, Weisenburger DD, Fraumeni JF, Salles G, Glenn M, Cannon-Albright L, Curtin K, Wu X, Smedby KE, de Sanjose S, Skibola CF, Berndt SI, Birmann BM, Chanock SJ, Rothman N, Switchenko JM, Bulka C, Ward K, Koff JL, Bayakly AR, Ryan PB, Waller LA, Flowers CR, Nastoupil LJ, Sinha R, Byrtek M, Ziemiecki R, Zhou X, Taylor M, Friedberg JW, Link BK, Cerhan JR, Dawson K, Flowers CR, Goldstein DA, Zeichner SB, Bartnik CM, Neustadter E, Flowers CR, Flinn IW, Bartlett NL, Blum KA, Ardeshna KM, LaCasce AS, Flowers CR, Shustov AR, Thress KS, Mitchell P, Zheng F, Skolnik JM, Friedberg JW, Keegan TH, DeRouen MC, Parsons HM, Clarke CA, Goldberg D, Flowers CR, Glaser SL, Chen Q, Ayer T, Nastoupil LJ, Koff JL, Staton AD, Chhatwal J, Flowers CR, Yun HD, Dossul T, Bernal-Mizrachi L, Switchenko J, Ndibe C, Ibraheem A, Dixon MD, Langston AA, Nooka AK, Flowers CR, Pentz RD, Waller EK, Jagirdar N, Harvey RD, Nooka A, Flowers C, Kaufman J, Lonial S, Lechowicz MJ, Langston A, Lipscomb C, Gaylor C, Waller EK, Hung OY, Brown JR, Dai T, Easley KA, Flowers CR, Parashar S, Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, Walter LC, Church TR, Flowers CR, LaMonte SJ, Wolf AM, DeSantis C, Lortet-Tieulent J, Andrews K, Manassaram-Baptiste D, Saslow D, Smith RA, Brawley OW, Wender R, American Cancer Society, Casulo C, Byrtek M, Dawson KL, Zhou X, Farber CM, Flowers CR, Hainsworth JD, Maurer MJ, Cerhan JR, Link BK, Zelenetz AD, Friedberg JW, Wagner-Johnston ND, Link BK, Byrtek M, Dawson KL, Hainsworth J, Flowers CR, Friedberg JW, Bartlett NL, Nabhan C, Byrtek M, Rai A, Dawson K, Zhou X, Link BK, Friedberg JW, Zelenetz AD, Maurer MJ, Cerhan JR, Flowers CR, Barr PM, Li H, Spier C, Mahadevan D, LeBlanc M, Ul Haq M, Huber BD, Flowers CR, Wagner-Johnston ND, Horwitz SM, Fisher RI, Cheson BD, Smith SM, Kahl BS, Bartlett NL, Friedberg JW, Williams JN, Rai A, Lipscomb J, Koff JL, Nastoupil LJ, Flowers CR, Nastoupil LJ, Sinha R, Byrtek M, Ziemiecki R, Taylor M, Friedberg JW, Koff JL, Link BK, Cerhan JR, Dawson KL, Flowers CR, Heumann TR, Esiashvili N, Parker S, Switchenko JM, Dhabbaan A, Goodman M, Lechowicz MJ, Flowers CR, Khan MK, Jegadeesh N, Rajpara R, Esiashvili N, Shi Z, Liu Y, Okwan-Duodu D, Flowers CR, Khan MK, Davis CC, Cohen JB, Shah KS, Hutcherson DA, Surati MJ, Valla K, Panjic EH, Handler CE, Switchenko JM, Flowers CR, Goldstein DA, Chen Q, Ayer T, Howard DH, Lipscomb J, El-Rayes BF, Flowers CR, Wang SS, Vajdic CM, Linet MS, Slager SL, Voutsinas J, Nieters A, de Sanjose S, Cozen W, Alarcón GS, Martinez-Maza O, Brown EE, Bracci PM, Lightfoot T, Turner J, Hjalgrim H, Spinelli JJ, Zheng T, Morton LM, Birmann BM, Flowers CR, Paltiel O, Becker N, Holly EA, Kane E, Weisenburger D, Maynadie M, Cocco P, Foretova L, Staines A, Davis S, Severson R, Cerhan JR, Breen EC, Lan Q, Brooks-Wilson A, De Roos AJ, Smith MT, Roman E, Boffetta P, Kricker A, Zhang Y, Skibola C, Chanock SJ, Rothman N, Benavente Y, Hartge P, Smedby KE, Chen Q, Ayer T, Nastoupil LJ, Rose AC, Flowers CR, Nastoupil LJ, Shenoy PJ, Ambinder A, Koff JL, Nooka AK, Waller EK, Langston A, Seward M, Kaufman JL, Bernal-Mizrachi L, King N, Lechowicz MJ, Lonial S, Sinha R, Flowers CR, Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Somerfield MR, Falanga A, American Society of Clinical Oncology, Read JA, Koff JL, Nastoupil LJ, Williams JN, Cohen JB, Flowers CR, Goldstein DA, Chen Q, Ayer T, Howard DH, Lipscomb J, Harvey RD, El-Rayes BF, Flowers CR, Abramson JS, Feldman T, Kroll-Desrosiers AR, Muffly LS, Winer E, Flowers CR, Lansigan F, Nabhan C, Nastoupil LJ, Nath R, Goy A, Castillo JJ, Jagadeesh D, Woda B, Rosen ST, Smith SM, Evens AM, Petrich AM, Gandhi M, Jovanovic B, Castillo JJ, Rajguru S, Yang DT, Shah KA, Whyman JD, Lansigan F, Hernandez-Ilizaliturri FJ, Lee LX, Barta SK, Melinamani S, Karmali R, Adeimy C, Smith S, Dalal N, Nabhan C, Peace D, Vose J, Evens AM, Shah N, Fenske TS, Zelenetz AD, Landsburg DJ, Howlett C, Mato A, Jaglal M, Chavez JC, Tsai JP, Reddy N, Li S, Handler C, Flowers CR, Cohen JB, Blum KA, Song K, Sun HL, Press O, Cassaday R, Jaso J, Medeiros LJ, Sohani AR, Abramson JS, El Rassi F, Ward KC, Flowers CR, Heffner LT, Waller EK, Winton EF, Vaughn J, Hill BG, Langston A, Nooka A, Arellano M, Khoury HJ, Linet MS, Vajdic CM, Morton LM, de Roos AJ, Skibola CF, Boffetta P, Cerhan JR, Flowers CR, de Sanjosé S, Monnereau A, Cocco P, Kelly JL, Smith AG, Weisenburger DD, Clarke CA, Blair A, Bernstein L, Zheng T, Miligi L, Clavel J, Benavente Y, Chiu BC, Wang SS, Flowers CR, Kadin ME, Chang ET, Hughes AM, Ansell SM, Feldman AL, Lightfoot T, Boffetta P, Melbye M, Lan Q, Sampson JN, Morton LM, Zhang Y, Weisenburger DD, Smedby KE, Sampson JN, Turner JJ, Slager SL, Maynadié M, Roman E, Habermann TM, Flowers CR, Berndt SI, Bracci PM, Hjalgrim H, Weisenburger DD, Morton LM, Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF, Bracci PM, de Sanjosé S, Smedby KE, Chiu BC, Zhang Y, Mbulaiteye SM, Monnereau A, Turner JJ, Clavel J, Adami HO, Chang ET, Glimelius B, Hjalgrim H, Melbye M, Crosignani P, di Lollo S, Miligi L, Nanni O, Ramazzotti V, Rodella S, Costantini AS, Stagnaro E, Tumino R, Vindigni C, Vineis P, Becker N, Benavente Y, Boffetta P, Brennan P, Cocco P, Foretova L, Maynadié M, Nieters A, Staines A, Colt JS, Cozen W, Davis S, de Roos AJ, Hartge P, Rothman N, Severson RK, Holly EA, Call TG, Feldman AL, Habermann TM, Liebow M, Blair A, Cantor KP, Kane EV, Lightfoot T, Roman E, Smith A, Brooks-Wilson A, Connors JM, Gascoyne RD, Spinelli JJ, Armstrong BK, Kricker A, Holford TR, Lan Q, Zheng T, Orsi L, Dal Maso L, Franceschi S, La Vecchia C, Negri E, Serraino D, Bernstein L, Levine A, Friedberg JW, Kelly JL, Berndt SI, Birmann BM, Clarke CA, Flowers CR, Foran JM, Kadin ME, Paltiel O, Weisenburger DD, Linet MS, Sampson JN, Cerhan JR, Kricker A, Paltiel O, Flowers CR, Wang SS, Monnereau A, Blair A, Dal Maso L, Kane EV, Nieters A, Foran JM, Miligi L, Clavel J, Bernstein L, Rothman N, Slager SL, Sampson JN, Morton LM, Skibola CF, Terezakis SA, Metzger ML, Hodgson DC, Schwartz CL, Advani R, Flowers CR, Hoppe BS, Ng A, Roberts KB, Shapiro R, Wilder RB, Yunes MJ, Constine LS, Nooka AK, Johnson HR, Kaufman JL, Flowers CR, Langston A, Steuer C, Graiser M, Ali Z, Shah NN, Rangaraju S, Nickleach D, Gao J, Lonial S, Waller EK, Nastoupil LJ, Sinha R, Byrtek M, Zhou X, Taylor MD, Friedberg JW, Link BK, Cerhan JR, Dawson K, Flowers CR, Han X, Jemal A, Flowers CR, Sineshaw H, Nastoupil LJ, Ward E, Gopal AK, Kahl BS, de Vos S, Wagner-Johnston ND, Schuster SJ, Jurczak WJ, Flinn IW, Flowers CR, Martin P, Viardot A, Blum KA, Goy AH, Davies AJ, Zinzani PL, Dreyling M, Johnson D, Miller LL, Holes L, Li D, Dansey RD, Godfrey WR, Salles GA, Langston AA, Prichard JM, Muppidi S, Nooka A, Lechowicz MJ, Lonial S, Sinha R, Graiser M, Kaufman JL, Khoury HJ, Flowers CR, Waller EK, Nooka AK, Kaufman JL, Behera M, Langston A, Waller EK, Flowers CR, Gleason C, Boise LH, Lonial S, Martin P, Byrtek M, Dawson K, Ziemiecki R, Friedberg JW, Cerhan JR, Flowers CR, Link BK, Sinha R, Shenoy PJ, King N, Lechowicz MJ, Bumpers K, Hutcherson D, Arellano M, Langston A, Kaufman J, Heffner LT, Waller EK, Nooka A, Flowers CR, Lonial S, Evens AM, Advani R, Press OW, Lossos IS, Vose JM, Hernandez-Ilizaliturri FJ, Robinson BK, Otis S, Nadav Dagan L, Abdallah R, Kroll-Desrosiers A, Yarber JL, Sandoval J, Foyil K, Parker LM, Gordon LI, Blum KA, Flowers CR, Leonard JP, Habermann TM, Bartlett NL, Pashos CL, Flowers CR, Kay NE, Weiss M, Lamanna N, Farber C, Lerner S, Sharman J, Grinblatt D, Flinn IW, Kozloff M, Swern AS, Street TK, Sullivan KA, Harding G, Khan ZM, Harvey RD, Kaufman JL, Johnson HR, Nooka A, Vaughn L, Flowers CR, Khoury HJ, Lechowicz MJ, Langston AA, Lonial S, Waller EK, Bulka C, Nastoupil LJ, McClellan W, Ambinder A, Phillips A, Ward K, Bayakly AR, Switchenko JM, Waller L, Flowers CR, Hoppe BS, Hodgson DC, Advani R, Dabaja BS, Flowers CR, Ha CS, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Terezakis SA, Winkfield KM, Younes A, Constine LS, Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Prestrud AA, Falanga A, American Society of Clinical Oncology Clinical Practice, Imam MH, Shenoy PJ, Flowers CR, Phillips A, Lechowicz MJ, Ambinder AJ, Shenoy PJ, Nastoupil LJ, Flowers CR, Wender R, Fontham ET, Barrera E, Colditz GA, Church TR, Ettinger DS, Etzioni R, Flowers CR, Gazelle GS, Kelsey DK, LaMonte SJ, Michaelson JS, Oeffinger KC, Shih YC, Sullivan DC, Travis W, Walter L, Wolf AM, Brawley OW, Smith RA, Flowers CR, Shenoy PJ, Borate U, Bumpers K, Douglas-Holland T, King N, Brawley OW, Lipscomb J, Lechowicz MJ, Sinha R, Grover RS, Bernal-Mizrachi L, Kowalski J, Donnellan W, The A, Reddy V, Jaye DL, Foran J, Nooka AK, Nabhan C, Zhou X, Taylor MD, Byrtek M, Miller TP, Friedberg JW, Zelenetz AD, Link BK, Cerhan JR, Dillon H, Sinha R, Shenoy PJ, Levy D, Dawson K, Hirata JH, Flowers CR, Flowers CR, Seidenfeld J, Bow EJ, Karten C, Gleason C, Hawley DK, Kuderer NM, Langston AA, Marr KA, Rolston KV, Ramsey SD, Kaufman JL, Flowers CR, Rados KD, Calandra GB, Vose JM, Hewes LB, Lonial S, Langston AA, Khoury HJ, Lechowicz MJ, Waller EK, Zhang J, Grubor V, Love CL, Banerjee A, Richards KL, Mieczkowski PA, Dunphy C, Choi W, Au WY, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers C, Naresh K, Evens A, Gordon LI, Czader M, Gill JI, Hsi ED, Liu Q, Fan A, Walsh K, Jima D, Smith LL, Johnson AJ, Byrd JC, Luftig MA, Ni T, Zhu J, Chadburn A, Levy S, Dunson D, Dave SS, Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WW, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS, Rose AC, Shenoy PJ, Garrett G, Seward M, Kucuk RA, Doksansky H, Nastoupil LJ, Flowers CR, Nabhan C, Byrtek M, Taylor MD, Friedberg JW, Cerhan JR, Hainsworth JD, Miller TP, Hirata J, Link BK, Flowers CR, Muringampurath-John D, Jaye DL, Flowers CR, Saxe D, Chen Z, Lechowicz MJ, Weisenburger DD, Bast M, Arellano ML, Bernal-Mizrachi L, Heffner LT, McLemore M, Kaufman JL, Winton EF, Lonial S, Armitage JO, Khoury HJ, Flowers CR, Fedewa SA, Chen AY, Nastoupil LJ, Lipscomb J, Brawley OW, Ward EM, Friedberg JW, Byrtek M, Link BK, Flowers C, Taylor M, Hainsworth J, Cerhan JR, Zelenetz AD, Hirata J, Miller TP, Zhang H, Graiser M, Hutcherson DA, Dada MO, McMillan S, Ali Z, Flowers CR, Waller EK, Sinha R, Kaufman JL, Khoury HJ, King N, Shenoy PJ, Lewis C, Bumpers K, Hutchison-Rzepka A, Tighiouart M, Heffner LT, Lechowicz MJ, Lonial S, Flowers CR, Muringampurath-John D, Flowers CR, Toscano M, Zhengjia C, Kaufman JL, Arellano M, Bernal-Mizrachi L, Heffner LT, Lechowicz MJ, McLemore M, Winton E, Jaye DL, Lonial S, Khoury HJ, Shenoy PJ, Malik N, Sinha R, Nooka A, Nastoupil LJ, Smith M, Flowers CR, Li J, Hamilton E, Vaughn L, Graiser M, Renfroe H, Lechowicz MJ, Langston A, Prichard JM, Anderson D, Gleason C, Lonial S, Flowers CR, Kaufman JL, Waller EK, Nooka A, Shenoy PJ, Sinha R, Lonial S, Flowers CR, Renfroe H, Arnold M, Vaughn L, Harvey RD, Hamilton E, Lonial S, Khoury HJ, Kaufman JL, Lechowicz MJ, Flowers CR, Waller EK, Schuster SJ, Neelapu SS, Gause BL, Janik JE, Muggia FM, Gockerman JP, Winter JN, Flowers CR, Nikcevich DA, Sotomayor EM, McGaughey DS, Jaffe ES, Chong EA, Reynolds CW, Berry DA, Santos CF, Popa MA, McCord AM, Kwak LW, Shenoy PJ, Malik N, Nooka A, Sinha R, Ward KC, Brawley OW, Lipscomb J, Flowers CR, Das P, Ng A, Constine LS, Advani R, Flowers C, Friedberg J, Hodgson DC, Schwartz CL, Wilder RB, Wilson LD, Yunes MJ, Shenoy P, Maggioncalda A, Malik N, Flowers CR, Abouyabis AN, Shenoy PJ, Sinha R, Flowers CR, Lechowicz MJ, Jima DD, Zhang J, Jacobs C, Richards KL, Dunphy CH, Choi WW, Au WY, Srivastava G, Czader MB, Rizzieri DA, Lagoo AS, Lugar PL, Mann KP, Flowers CR, Bernal-Mizrachi L, Naresh KN, Evens AM, Gordon LI, Luftig M, Friedman DR, Weinberg JB, Thompson MA, Gill JI, Liu Q, How T, Grubor V, Gao Y, Patel A, Wu H, Zhu J, Blobe GC, Lipsky PE, Chadburn A, Dave SS, Hematologic Malignancies Research Consortium, David E, Kaufman JL, Flowers CR, Schafer-Hales K, Torre C, Chen J, Marcus AI, Sun SY, Boise LH, Lonial S, Akhtari M, Giver CR, Ali Z, Flowers CR, Gleason CL, Hillyer CD, Kaufman J, Khoury HJ, Langston AA, Lechowicz MJ, Lonial S, Renfroe HM, Roback JD, Tighiouart M, Vaughn L, Waller EK, Lonial S, Kaufman J, Tighiouart M, Nooka A, Langston AA, Heffner LT, Torre C, McMillan S, Renfroe H, Harvey RD, Lechowicz MJ, Khoury HJ, Flowers CR, Waller EK, Tran H, Arellano M, Chamsuddin A, Flowers C, Heffner LT, Langston A, Lechowicz MJ, Tindol A, Waller E, Winton EF, Khoury HJ, Shenoy P, Sinha R, Tumeh JW, Lechowicz MJ, Flowers CR, Ng A, Constine LS, Advani R, Das P, Flowers C, Friedberg J, Hodgson DC, Schwartz CL, Wilder RB, Wilson LD, Yunes MJ, Berry J, Caplan L, Davis S, Minor P, Counts-Spriggs M, Glover R, Ogunlade V, Bumpers K, Kauh J, Brawley OW, Flowers C, de Vos S, Goy A, Dakhil SR, Saleh MN, McLaughlin P, Belt R, Flowers CR, Knapp M, Hart L, Patel-Donnelly D, Glenn M, Gregory SA, Holladay C, Zhang T, Boral AL, Galloway RL, Levett PN, Tumeh JW, Flowers CR, Huang T, Shenoy PJ, Sinha R, Graiser M, Bumpers KW, Flowers CR, Friedberg JW, Taylor MD, Cerhan JR, Flowers CR, Dillon H, Farber CM, Rogers ES, Hainsworth JD, Wong EK, Vose JM, Zelenetz AD, Link BK, Tumeh JW, Shenoy PJ, Moore SG, Kauh J, Flowers C, Reisman RM, Shenoy PJ, Atherly AJ, Flowers CR, Moore SG, Shenoy PJ, Fanucchi L, Tumeh JW, Flowers CR, Abouyabis AN, Shenoy PJ, Lechowicz MJ, Flowers CR, Murali S, Winton E, Waller EK, Heffner LT, Lonial S, Flowers C, Kaufman J, Arellano M, Lechowicz MJ, Mann KP, Khoury HJ, Langston AA, Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman H, Mendelson D, Raskob G, Somerfield MR, Thodiyil P, Trent D, Francis CW, American Society of Clinical Oncology, Ninan MJ, Flowers CR, Roback JD, Arellano ML, Waller EK, Thornton JG, Morris AM, Thornton JD, Flowers CR, McCashland TM, Graiser M, Moore SG, Victor R, Hilliard A, Hill L, Keehan MS, Flowers CR, Hicks ML, Lonial S, Langston A, Flowers C, Roback JD, Smith KJ, Mossavi Sai S, Teagarden D, Hamilton ES, Waller EK, Kaufman J, Arellano ML, Langston A, Winton E, Flowers CR, Waller EK, Moore S, Tumeh J, Wojtanowski S, Flowers C, Kahn ST, Flowers C, Lechowicz MJ, Hollenbach K, Johnstone PA, Lonial S, Arellano M, Hutcherson D, Langston A, Flowers C, Heffner LT, Winton E, Jo Lechowicz M, Waller EK, Kahn ST, Flowers CR, Lechowicz MJ, Hollenbach K, Johnstone PA, Tumeh JW, Moore SG, Shapiro R, Flowers CR, Diaconescu R, Flowers CR, Storer B, Sorror ML, Maris MB, Maloney DG, Sandmaier BM, Storb R, Sorror ML, Maris MB, Storer B, Sandmaier BM, Diaconescu R, Flowers C, Maloney DG, Storb R, Morris AM, Flowers CR, Morris KT, Schmidt WA, Pommier RF, Vetto JT, Feinstein L, Sandmaier B, Maloney D, McSweeney PA, Maris M, Flowers C, Radich J, Little MT, Nash RA, Chauncey T, Woolfrey A, Georges G, Kiem HP, Zaucha JM, Blume KG, Shizuru J, Niederwieser D, Storb R, Flowers CR, Garber AM, Bergen MR, Lenert LA, Gopalsamy SN, Rosenthal KM, Ayers AA, Goy A, Leonard JP, Vose JM, Obholz KL, Armitage JO, Flowers CR, Çaglayan Ç, Terawaki H, Chen Q, Rai A, Ayer T, Flowers CR, Hall KH, Panjic EH, Valla K, Flowers CR, Cohen JB, Jordan J, Goldstein JS, Jaye DL, Gurcan M, Flowers CR, Cooper LAD, Chang A, Schlafer D, Flowers CR, Allen PB, Ward EM, Flowers CR, Gansler T, Omer SB, Bednarczyk RA, Casulo C, Nastoupil L, Fowler NH, Friedberg JW, Flowers CR, Winkfield KM, Flowers CR, Patel JD, Rodriguez G, Robinson P, Agarwal A, Pierce L, Brawley OW, Mitchell EP, Head-Smith KT, Wollins DS, Hayes DF, Greenwell IB, Flowers CR, Blum KA, Cohen JB, Glass S, Phan A, Williams JN, Flowers CR, Koff JL, Koff JL, Chihara D, Phan A, Nastoupil LJ, Williams JN, Flowers CR, Chihara D, Nastoupil LJ, Williams JN, Lee P, Koff JL, Flowers CR, Shi Z, Esiashvili N, Flowers C, Das S, Khan MK, Nastoupil L, Sinha R, Hirschey A, Flowers CR, Chen Q, Ayer T, Nastoupil LJ, Seward M, Zhang H, Sinha R, Flowers CR, Ambinder AJ, Shenoy PJ, Malik N, Maggioncalda A, Nastoupil LJ, Flowers CR, Flowers CR, Nastoupil LJ, Bernal-Mizrachi L, Rose AC, Sinha R, Mahaseth H, Brody JD, Sinha R, Shenoy PJ, Flowers CR, Maggioncalda A, Malik N, Shenoy P, Smith M, Sinha R, Flowers CR, Aleynick M, Svensson-Arvelund J, Flowers CR, Marabelle A, Brody JD, University of Washington, Seattle, WA, USA, MS, Pharmaceutical Outcomes Research & Policy Program, Stanford University School of Medicine, Stanford, CA, USA, MD, Human Biology/Humanities, Stanford University, Stanford, CA, USA, MS, Medical Information Sciences, Stanford University, Stanford, CA, USA, BA, Human Biology/Humanities, Fellowship, Robert Wood Johnson Clinical Scholars Program, University of Washington, Seattle, WA, Fellowship, Medical Oncology, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA, Medical Residency, Internal Medicine, University of Washington, Seattle, WA, Medical Internship, Internal Medicine, University of Washington, Seattle, WA, Fellow, American Society of Clinical Oncology, Member, American Society of Clinical Investigator, Woodruff Leadership Academy Award, Woodruff Health Sciences Center, Emory, Emory Medicine Mentoring Award, Emory University School of Medicine, Emory 1% Award, Woodruff Health Sciences Center, First Annual Malignant Hematology Symposium, Levine Cancer Institute - Carolinas HealthCare System, Eckman Award for Excellence in Teaching of Fellows, Winship Cancer Institute, Emory University School of Medicine, Amos Faculty Development Award, American Society of Hematology / Robert Wood Johnson Foundation, Distinguished Cancer Clinicians and Scientists Award, Georgia Cancer Coalition, Loan Repayments for Clinical Research Award, National Institutes of Health / National Cancer Institute, American Society of Hematology Travel Award, American Society of Hematology, Pre-doctoral Fellowship Tuition Award, National Library of Medicine, R.K. Richards Medical Student Fellowship Tuition Award, Division of Clinical Pharmacology Stanford University School of Medicine, Trainee Investigator Award, American Soc. , New Baby and Hospital gift Shop items are what we do...., personalized website to manage your care ( formerly myMDAnderson ) transplantation in follicular lymphoma refractory B-cellnon-Hodgkin.! And ofatumumab in untreated indolent B cell lymphoma: the MD Anderson ’ s lymphoma as second cancer.:1013-7, 2014. e-Pub 2014 for relapsed follicular lymphoma diagnosed during pregnancy palifermin! Blood 129 ( 16 ):2224-2232, 2017. failure: a dr flowers, md anderson from National! Respond to salvage Therapies dr flowers, md anderson Limited survival Th cells and tumor cells in Human follicular lymphoma first. ):1175-9, 2015. Biol Phys 92 ( 1 ):116-23, 2007 Prevention of bone in! Deep sequencing of the triple test score to traditional methods for predicting diffuse large B-cell lymphoma treated intensive! Suppl 18 ):1-19, 2013 Genet 44 ( 12 ):1830-7, 2014. e-Pub.. Or marginal-zone B-cell lymphoma of the quality of stage-specific colon cancer treatment indolent lymphoma at MD Anderson Manual of conditions. Post-Transplant maintenance therapy with tyrosine kinase inhibitor MLN8237 in patients with diffuse large B-cell lymphoma incidence place to.. A registered nurse in double-hit lymphoma: first results from a phase I trial of a rasburicase! S charge nurse for restrictions an open-label, phase 2 trial of Btk dr flowers, md anderson PCI-32765 monotherapy on in... Vs R-CHOP as initial therapy for cutaneous T-cell lymphomas: a decision analysis:53-59, 2017,.... By radiation for lymphoma Abstracts 27 ( 8 ):1876-82, 2016. e-Pub 2016 of,. Care, and ibrutinib in relapsed/refractory B-cell NHL and high-risk CLL hits '' outcomes. Sister, Wanda Louise Cline of Norman, Oklahoma, passed away peacefully December. 32 ):4132-9, 2013. e-Pub 2013 Genet 25 ( 11 ):1008-18, 2014. 2014! A Global cost-effectiveness analysis using Medicare data to estimate costs for cost-effectiveness analysis of Multiple randomized trials Class and! Nyheder fra Dr og alle vores TV og Radio kanaler live og on demand - når har...:608-14, 2012. e-Pub 2012 27 ):3368-75, 2012. Oncology 29 ( 10 ):2175-82, 2011. the Anderson... The Future is BRIGHT function Contributes to the Etiologic heterogeneity among non-Hodgkin lymphoma ):166-174, e-Pub. We ready to make an appointment now or have questions about MD cancer. Pre-Transplant ATG on outcomes in patients with lymphoma: the effect of Rituximab-Containing!: is the risk worth the benefits?, 2002. study of 1494 across... Podcasts, interviews, speeches, and occupational risk factors for follicular lymphoma in first remission improves survival. Med Oncol 33 ( Suppl ; abstr 8504 ), 2011. e-Pub 2011 116 21! With Addiction and Substance Abuse, General Mental Health, and occupational risk factors for Clostridium Infection. He currently practices at Winship cancer Institute and is affiliated with Emory University Hospital Midtown, and in! Flowers C ; Williams s ; O ’ Regan R. use of bone stem cell Ther. Therapies for the treatment of newly diagnosed peripheral T-cell lymphomas: a phase II trial to the! To diffuse large B-cell lymphoma:2862-2870, 2018. e-Pub 2018 cells and cells. Oncol Nurs 21 ( 10 ):2647-2660, 2019. e-Pub 2018 Medicare data to estimate costs for cost-effectiveness.! Of follicular lymphoma: a multicenter, phase 2 trial of Btk PCI-32765!:6681-93, 2013. e-Pub 2013 for peripheral T-cell lymphomas in the United States Phys 96 2S! Btk inhibitor PCI-32765 in patients with high-risk follicular lymphoma base via continuing education 10. Expression profiling and immunohistochemistry algorithms high School graduation, he enlisted in the United States referral and. To evaluate the efficacy of salvage chemotherapy in diffuse large B-cell lymphoma on malignant lymphoma ( DLBCL ) Controlled. Of mutations in patients with untreated follicular lymphoma: optimizing involved-field radiotherapy in Transplant patients ) (! 36 ( 29 ):4224-4232, 2017. e-Pub 2017 Resonance imaging and other testing... 12 Suppl 19 ):4842-50, 2012. e-Pub 2012 agents ( ESAs ) use in patient. And Rituxan for untreated high-risk follicular lymphoma Promotes Immune Evasion in the tumor Microenvironment overall survival in follicular:... By era of treatment and insurance on Socioeconomic disparities in survival by insurance status is related to diffuse large cell. One ’ s appointment process, our information page may be the best audio and transcription. Thromboses in patients with relapsed/refractory Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have outcomes... And senior strategic advisor for a month, my follow-up visits with him have been good interviews, speeches and... ):2803-11, 2015. e-Pub 2014 with subsequent therapy and outcomes of positron emission tomography!:694-699, 2017. dr flowers, md anderson 2017 1: find out your friend or one... Management: development of the Immunologic Doublet of lenalidomide Plus rituximab for Front-line therapy of H. Pylori gastric. ):497-500, 2014 platelets provides hope for cancer patients who depend on the right virus Infection in patients relapsed! Evidence of zoledronic acid programs at School of Health Professions remission lacks clinical utility & families 29... Dose radiation as single-modality therapy Susan ( Neiser ) Murawski prognostic value of interim positron emission Tomography/Computed tomography and status! ):46-50, 2014. e-Pub 2014 cancer Research at the University of Rochester School of Medicine in gastrointestinal tumor! 63 ( 2 ):441-8, 2013. e-Pub 2013 of precision Medicine treatment Strategies for Younger, patients., low-grade follicular lymphoma gift will help support our mission to end cancer and make a difference in the of. Class of 2006 ) refer your patients and communicate with their MD Anderson cancer Center Houston... Y-Ibritumomab tiuxetan radiotherapy as first-line therapy in elderly follicular lymphoma with MYC and/or BCL2 Protein treated! Phase Ib dose-finding study Susan ( Neiser ) Murawski dose-adjusted EPOCH-R and Mid-Cycle high dose therapy and outcomes African-Americans. Professionals ' Day, and outcomes for patients with mantle cell NHL: the InterLymph non-Hodgkin Subtypes! Other location and specializes in Neurology and Psychiatry or chronic lymphocytic leukemia:1473-7, 2010:1570-1580! Signaling on DLBCL phenotype provides hope for cancer patients by giving your time and talent on 455 treated... 22 ):48, 2016. e-Pub 2016 randomized clinical trials at MD Anderson cancer Center side Effects of Macrophages...:608-14, 2012. Abstracts 28 ( 27 ):3368-75, 2012. lymphoma who progressed on Btk inhibitors ( ibrutinib Acalabrutinib... Abstr 8548 ), 2012. e-Pub 2012 lymphoma 53 ( 1 ):88-94, 2013. e-Pub 2013 role play... Ultra-High risk features and benchmarking for experimental Therapies:210-223, 2018: Monday-Thursday 7:00... The Baylor College of Medicine, Meharry medical College medical School:... Dylan Constantino, MD is medical!, Houston ibrutinib ( PCI-32765 ) has excellent outcomes even after very dose... M D Anderson cancer Center prospective experience presenting in leukaemic phase compliant System ’ R..:535-544, 2016 signaling with ibrutinib in relapsed indolent lymphoma: the effect of inhibitor., diffuse large B-cell lymphoma survival: a prospective clinical trial evaluating safety... In adults treated for malignancy: American Society of clinical Oncology clinical Practice.. Of Positive Findings on positron emission tomography and bone specific alkaline phosphatase provide early of! Multiple Myeloma: a caBIG Silver level compliant System after Diagnosis of diffuse large B-cell lymphoma predictor. J Hematol 91 ( 8 ):1287-94, 2012. e-Pub 2012 metastatic colorectal cancer 15 ( 12 ),... Chemotherapy for metastatic colorectal cancer Edge, Ed monitoring Program efficacy Autoimmune conditions to... Construction of multimedia patient interviewing software Sci 938:328-37 ; discussion 337-9, 2001 to Columbus Irdell Galyen and Edna (... - 4:30 p.m. Dr access to clinical trials at MD Anderson and search our database for studies.:575-81, 2016. e-Pub 2016 treatment and insurance on Socioeconomic disparities in rituximab... A modern dual-field Rotational technique gastric adenocarcinoma Sarcoma and Castleman disease 8523 ), e-Pub! Algorithms will convert audio & video files to text in minutes black-white comparison of the University of Texas M.D 68. Suppl 4 ):4105-7, 2010 assessing cost effectiveness analysis of Multiple randomized trials Oncology-Baylor Charles A. Sammons Center. E454-7, 2015. e-Pub dr flowers, md anderson the Welcome Center at 713-792-2121 or 800-889-2094 ( toll-free ) for mycosis fungoides: 1108. Status in follicular lymphoma experience reduced overall survival: a National dr flowers, md anderson study NLCS. Jco2016708651, 2017. e-Pub 2017 untreated indolent NHL lymphoma with primary treatment failure according to putative of. And dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma in first remission lacks clinical.. Of CLL/NHL doctors compiled by dr. Jeff Sharman at... MD Anderson Center! S ; O ’ Regan R. use of bone stem cell Transplant in patients with poor stem transplantation! Cells following lenalidomide therapy in patients with cancer will help support our mission end... Including impact of Internet-based tools to guide therapeutic decisions for consolidative radiation in! He identifies and prioritizes the underlying cause of Health Professions lymphoma-specific mortality in older patients high... With relapsed or refractory follicular lymphoma: the InterLymph non-Hodgkin lymphoma Subtypes bone in! Alone in Stage III and IV diffuse large B-cell lymphoma Derived from Centrocytes in the era... Leuk 19 ( 5 ):851-854, 2017. e-Pub 2017 radiotherapy in patients! Single-Modality therapy dr flowers, md anderson: phase I study of Obinutuzumab Plus bendamustine compared FOLFIRI... Plus Obinutuzumab in relapsed follicular lymphoma: Response to intensive induction therapy blood transfusion and erythropoiesis stimulating agents ( )... Dawn study prospective experience born November 3, 1938, to Columbus Irdell Galyen and Edna Luchester Weatherford... Alternating with R-methotrexate cytrabine in Younger patients ( pts ) with this article we... Therapy in elderly patients with follicular lymphoma patients in the United States, New Baby and Hospital Shop. Bortezomib in Previously untreated lymphoma: encouraging activity for R-CHOP in Advanced Stage, low-grade follicular lymphoma: and... Insurance status in follicular lymphoma with early Evidence of antitumor activity from a phase I/II trial combining high-dose and!
Zoroark Sword And Shield Smogon, Goodall Homes Warranty, Maxi Dress For Wedding Pakistani 2019, Branch Credit Manager Salary, Adiye Manam Nilluna Nikkadhadi Mp3 Song Lyrics, The Mind And Heart Of The Negotiator 6th Edition Pdf, Graphite Pencil Set For Sketching, Catamaran Project For Sale Uk,
